Ledger.Open graph →
SEC Form D · Amendment · filed February 11, 2025

Sea Pharmaceuticals, LLC

Offering
$2.2M
Sold
$417K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Shaker J. Sadasivam · CAMBRIDGE, MADirectorMark G. Currie · CAMBRIDGE, MADirectorWalter K. Brown · CAMBRIDGE, MADirectorEric R. Olson · CAMBRIDGE, MADirectorJames P. Pearson · CAMBRIDGE, MAExec · DirectorMichael F. Higgins · CAMBRIDGE, MADirectorNabil J. Elkouh · CAMBRIDGE, MADirectorNabil J. Elkouh · CAMBRIDGE, MADirectorEric R. Olson · CAMBRIDGE, MADirectorWalter K. Brown · CAMBRIDGE, MADirectorMichael F. Higgins · CAMBRIDGE, MADirectorJames P. Pearson · CAMBRIDGE, MAExec · DirectorShaker J. Sadasivam · CAMBRIDGE, MADirectorMark G. Currie · CAMBRIDGE, MADirectorAlbert Siu · Englewood Cliffs, NJDirectorMariel Reilly · Englewood Cliffs, NJDirectorHenry Van Dyke · Englewood Cliffs, NJDirectorJeffrey Schwartz · BOSTON, MADirectorMazen Darwazah · San Diego, CADirectorSuzane San · San Diego, CAExec · DirectorMinami Maeda · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗